Navidea Competitors

NAVB Stock  USD 0.0001  0.00  0.00%   
Analyzing Navidea Biopharmaceutica competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Navidea Biopharmaceutica to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Navidea Biopharmaceutica competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Navidea Biopharmaceutica's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00008750.01
Details
Intrinsic
Valuation
LowRealHigh
0.000.00009650.01
Details

Navidea Biopharmaceutica Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Navidea Biopharmaceutica and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Navidea and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Navidea Biopharmaceutica does not affect the price movement of the other competitor.

High positive correlations

WPDPFGNBT
NNMXGNBT
NMDBFGNBT
GLSHQGNBT
MOSTQGNBT
GDBYFGNBT
  

High negative correlations

ACORQMGFRF
ACORQCRXM
MGFRFCRXM
ACORQGDBYF
MGFRFGDBYF
CRXMGDBYF

Risk-Adjusted Indicators

There is a big difference between Navidea Pink Sheet performing well and Navidea Biopharmaceutica Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Navidea Biopharmaceutica's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
GNBT  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
WPDPF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
NNMX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
NMDBF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
GLSHQ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
MOSTQ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
GDBYF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CRXM  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
MGFRF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ACORQ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Navidea Biopharmaceutica Competitive Analysis

The better you understand Navidea Biopharmaceutica competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Navidea Biopharmaceutica's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Navidea Biopharmaceutica's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
NAVB NNMX GLSHQ MOSTQ MGFRF
 0.00 
 0.0001 
Navidea
 0.00 
 0.0002 
Nanomix
 0.00 
 0.0001 
Gelesis
 0.00 
 0.0003 
MobileSmith
 0.00 
 0.0004 
MagForce
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Current Valuation
Price To Book
Operating Margin
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Z Score
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Rate Of Daily Change
Day Median Price
Day Typical Price
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Standard Deviation
Kurtosis
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Information Ratio

Navidea Biopharmaceutica Competition Performance Charts

Five steps to successful analysis of Navidea Biopharmaceutica Competition

Navidea Biopharmaceutica's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Navidea Biopharmaceutica in relation to its competition. Navidea Biopharmaceutica's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Navidea Biopharmaceutica in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Navidea Biopharmaceutica's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Navidea Biopharmaceutica, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Navidea Biopharmaceutica position

In addition to having Navidea Biopharmaceutica in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Alcohol Thematic Idea Now

Alcohol
Alcohol Theme
Companies involved in production and distribution of wines and alcoholic beverages. The Alcohol theme has 10 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alcohol Theme or any other thematic opportunities.
View All  Next Launch

Additional Information and Resources on Investing in Navidea Pink Sheet

When determining whether Navidea Biopharmaceutica is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Navidea Pink Sheet is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Navidea Biopharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Navidea Biopharmaceuticals Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Please note, there is a significant difference between Navidea Biopharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Navidea Biopharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Navidea Biopharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.